Anyone going to the AGM? It would be good to get a formal answer about
a) Confirmation oraline is DEAD, update on "dust mite trial", update on $100k invested in technology accelerator program - why was this immediately written down to nil in 2015 financial statements?
b) An update on Dimerix - have patients actually been dosed yet? Are preliminary results still on track to be delivered in 1st half of 2016?
c) The reasons why 2 board members left suddenly (I say suddenly because a trading halt indicates that the company did not know this was going to happen)
d) The reason why so many shares and options were issued to Forrest Capital in addition to Forrest's fee for services, over the last few years
e) What the new board plan to do to in the short, medium and long term to build the company and most importantly increase share price from these lows
SBN Price at posting:
0.6¢ Sentiment: None Disclosure: Held
